A carregar...
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
BACKGROUND: Currently available disease-modifying treatments acting by modifying the immune response are ineffective in progressive multiple sclerosis (MS), which is caused by a widespread axonal degeneration. Mechanisms suspected to be involved in this widespread axonal degeneration are reduced axo...
Na minha lista:
Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
BioMed Central
2014
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3931920/ https://ncbi.nlm.nih.gov/pubmed/24460863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-37 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|